File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?

TitleNeurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?
Authors
Chiu, KChan, TFWu, ALeung, IYPSo, KFChang, RCC
KeywordsAge-related macular degeneration
Alzheimer's disease
Glaucoma
Inner nuclear layer
Neurodegeneration
Retina
Retinal ganglion cells
Issue Date2012
PublisherSpringer Netherlands. The Journal's web site is located at http://www.springerlink.com/content/0161-9152/
Citation
Age, 2012, v. 34 n. 3, p. 633-649 How to Cite?
DOI: http://dx.doi.org/10.1007/s11357-011-9260-2
AbstractAlzheimer's disease (AD) is an age-related progressive neurodegenerative disease commonly found among elderly. In addition to cognitive and behavioral deficits, vision abnormalities are prevalent in AD patients. Recent studies investigating retinal changes in AD double-transgenic mice have shown altered processing of amyloid precursor protein and accumulation of β-amyloid peptides in neurons of retinal ganglion cell layer (RGCL) and inner nuclear layer (INL). Apoptotic cells were also detected in the RGCL. Thus, the pathophysiological changes of retinas in AD patients are possibly resembled by AD transgenic models. The retina is a simple model of the brain in the sense that some pathological changes and therapeutic strategies from the retina may be observed or applicable to the brain. Furthermore, it is also possible to advance our understanding of pathological mechanisms in other retinal degenerative diseases. Therefore, studying AD-related retinal degeneration is a promising way for the investigation on (1) AD pathologies and therapies that would eventually benefit the brain and (2) cellular mechanisms in other retinal degenerations such as glaucoma and age-related macular degeneration. This review will highlight the efforts on retinal degenerative research using AD transgenic mouse models. © 2011 The Author(s).
Persistent Identifierhttp://hdl.handle.net/10722/135016
ISSN
0161-9152
2018 Impact Factor: 4.648
PubMed Central ID
PMC3337933
ISI Accession Number ID
WOS:000303507400010
Funding AgencyGrant Number
HKU Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging
Strategic Research Theme on Drug Discovery
Azalea
HKU20097176185
Funding Information:

Research in this laboratory is partly supported by HKU Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging, Strategic Research Theme on Drug Discovery, Azalea (1972) Endowment Fund, and HKU Small Project Fund (20097176185).

References

Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411–431 doi: 10.1016/S0002-9394(02)01624-0

Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV (2004) Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res 78:243–256 doi: 10.1016/j.exer.2003.10.011

Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF (2004) Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer’s disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res 1012:29–41 doi: 10.1016/j.brainres.2004.02.081

Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Goggins WB, Zee BC, Cheng KF, Fong CY, Wong A, Mok H, Chow MS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CY, Chan MH, Szeto S, Chan IH, Mok V (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28:110–113 doi: 10.1097/jcp.0b013e318160862c

Bayer TA, Wirths O (2008) Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment. Genes Brain Behav 7(Suppl 1):6–11 doi: 10.1007/s12177-009-9035-5

Yu MS, Lai CS, Ho YS, Zee SY, So KF, Yuen WH, Chang RCC (2007) Characterization of the effects of anti-aging medicine Fructus lycii on beta-amyloid peptide neurotoxicity. Int J Mol Med 20:261–268 doi: 10.1016/S0028-3932(00)00023-3

Shimazawa M, Ito Y, Inokuchi Y, Hara H (2007) Involvement of Double-Stranded RNA-Dependent Protein Kinase in ER Stress-Induced Retinal Neuron Damage. Invest Ophthalmol Vis Sci 48:3729–3736 doi: 10.1111/j.1471-4159.2007.04613.x

Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer’s disease. J Neurosci 21:372–381 doi: 10.1016/j.bmcl.2010.09.029

Rodrigues EB (2007) Inflammation in dry age-related macular degeneration. Ophthalmologica 221:143–152 doi: 10.1111/j.1600-0420.1996.tb00090.x

Chiu K, Zhou Y, Yeung SC, Lok CK, Chan OO, Chang RCC, So KF, Chiu JF (2010) Up-regulation of crystallins is involved in the neuroprotective effect of wolfberry on survival of retinal ganglion cells in rat ocular hypertension model. J Cell Biochem 110:311–320 doi: 10.1242/jcs.070490

Spires TL, Hyman BT (2005) Transgenic models of Alzheimer’s disease: learning from animals. NeuroRx 2:423–437 doi: 10.1602/neurorx.2.3.423

Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051–1063 doi: 10.2174/156720510790274491

Caroni P (1997) Overexpression of growth-associated proteins in the neurons of adult transgenic mice. J Neurosci Methods 71:3–9 doi: 10.1083/jcb.200108057

Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356 doi: 10.1523/JNEUROSCI.0519-10.2010

Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Långström B (2004) Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol 55:306–319 doi: 10.1016/S0006-8993(01)03058-X

Jimenez S, Baglietto-Vargas D, Caballero C, Moreno-Gonzalez I, Torres M, Sanchez-Varo R, Ruano D, Vizuete M, Gutierrez A, Vitorica J (2008) Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer’s disease: age-dependent switch in the microglial phenotype from alternative to classic. J Neurosci 28:11650–11661 doi: 10.1016/S0002-9440(10)64893-6

Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P, Van Leuven F (2005) Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J Biol Chem 280:3963–3973 doi: 10.1016/j.preteyeres.2003.10.003

Malamas MS, Robichaud A, Erdei J, Quagliato D, Solvibile W, Zhou P, Morris K, Turner J, Wagner E, Fan K, Olland A, Jacobsen S, Reinhart P, Riddell D, Pangalos M (2010) Design and synthesis of aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors with enhanced brain permeability. Bioorg Med Chem Lett 20:6597–6605 doi: 10.1001/archopht.122.4.598

Chang RCC, Suen KC, Ma CH, Elyaman W, Ng HK, Hugon J (2002a) Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2 alpha in neuronal degeneration. J Neurochem 83:1215–1225 doi: 10.1523/JNEUROSCI.3024-08.2008

Garcia MF, Gordon MN, Hutton M, Lewis J, McGowan E, Dickey CA, Morgan D, Arendash GW (2004) The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer’s transgenic mice. Neuroreport 15:73–77 doi: 10.1126/science.1072994

Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, Drobecq H, Clark A, Bonici B, Delacourte A, Benavides J, Schmitz C, Tremp G, Bayer TA, Benoit P, Pradier L (2004) Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 165:1289–1300 doi: 10.1016/S0002-9440(10)63388-3

Nimmrich V, Grimm C, Draguhn A, Barghorn S, Lehmann A, Schoemaker H, Hillen H, Gross G, Ebert U, Bruehl C (2008) Amyloid beta oligomers (A beta(1–42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci 28:788–797 doi: 10.1016/S0166-4328(99)00037-6

Chan HC, Chang RCC, Koon-Ching Ip A, Chiu K, Yuen WH, Zee SY, So KF (2007) Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Exp Neurol 203:269–273 doi: 10.1016/j.biocel.2009.05.013

Ho YS, Yu MS, Yang XF, So KF, Yuen WH, Chang RCC (2010a) Neuroprotective effects of polysaccharides from wolfberry, the fruits of Lycium barbarum, against homocysteine-induced toxicity in rat cortical neurons. J Alzheimers Dis 19:813–827 doi: 10.1016/j.brainres.2005.04.016

Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL (2007) Retinal abnormalities in early Alzheimer’s disease. Invest Ophthalmol Vis Sci 48:2285–2289 doi: 10.1007/s00417-009-1060-3

Duyckaerts C, Potier MC, Delatour B (2008) Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol 115:5–38 doi: 10.1007/s00401-007-0312-8

Eriksen JL, Janus CG (2007) Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet 37:79–100 doi: 10.1167/iovs.08-2384

Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL (2011) Identification of amyloid plaques in retinas from Alzheimer’s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54(Suppl 1):S204–S217 doi: 10.1007/s10519-006-9118-z

Frank S, Clavaguera F, Tolnay M (2008) Tauopathy models and human neuropathology: similarities and differences. Acta Neuropathol 115:39–53 doi: 10.1007/s00401-007-0291-9

Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP (2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24:516–524 doi: 10.2353/ajpath.2009.090159

McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, Ransom NL, Tahzib NG, Reitsamer HA, Levkovitch-Verbin H, Quigley HA, Zack DJ (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43:1077–1087 doi: 10.4061/2010/417314

Grundke-Iqbal I, Iqbal K, George L, Tung YC, Kim KS, Wisniewski HM (1989) Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc Natl Acad Sci USA 86:2853–2857 doi: 10.1073/pnas.86.8.2853

Guo L, Salt TE et al (2007) Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA 104:13444–13449 doi: 10.1002/glia.440030605

Gasparini L, Anthony Crowther R, Martin KR, Berg N, Coleman M, Goedert M, Spillantini MG (2009) Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Neurobiol Aging 32:419–433 doi: 10.1097/IJG.0b013e318181284f

Perez SE, Lumayag S, Kovacs B, Mufson EJ, Xu S (2009) Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer’s disease. Invest Ophthalmol Vis Sci 50:793–800 doi: 10.1126/science.274.5284.99

Hung CH, Ho YS, Chang RCC (2010) Modulation of mitochondrial calcium as a pharmacological target for Alzheimer’s disease. Ageing Res Rev 9:447–456 doi: 10.1016/j.arr.2010.05.003

Pezzini A, Del Zotto E, Volonghi I, Giossi A, Costa P, Padovani A (2009) Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage. Curr Med Chem 16:2498–2513 doi: 10.1016/0006-8993(93)90695-J

Yin H, Chen L, Chen X, Liu X (2008) Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma. Med Hypotheses 71:77–80 doi: 10.1016/j.neuroimage.2010.06.020

LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci 8:499–509 doi: 10.1016/j.neurobiolaging.2006.08.013

Li M, Chen L, Lee DH, Yu LC, Zhang Y (2007) The role of intracellular amyloid beta in Alzheimer’s disease. Prog Neurobiol 83:131–139 doi: 10.1523/JNEUROSCI.1357-09.2009

Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, Rizzuto R, Hajnoczky G (2008) Bidirectional Ca2+−dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci USA 105:20728–20733 doi: 10.1523/JNEUROSCI.4771-07.2008

Luibl V, Isas JM, Kayed R, Glabe CG, Langen R, Chen J (2006) Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest 116:378–385 doi: 10.1016/0197-4580(96)00010-3

Moechars D, Dewachter I, Lorent K, Reversé D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274:6483–6492 doi: 10.1074/jbc.M409876200

Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease. Nature 408:982–985 doi: 10.1038/35050116

Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905–909 doi: 10.1038/416535a

Ning A, Cui J, To E, Ashe KH, Matsubara J (2008) Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci 49:5136–5143 doi: 10.1016/j.clineuro.2007.10.011

Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, Chen Y, Zhang K, Ambati BK, Baffi JZ, Ambati J (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 103:2328–2333 doi: 10.1073/pnas.0408835103

Ding JD, Lin J, Mace BE, Herrmann R, Sullivan P, Bowes Rickman C (2008) Targeting age-related macular degeneration with Alzheimer’s disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Vision Res 48:339–345 doi: 10.1172/JCI24635

Santos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI, Zhu X (2010) A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer’s disease. J Alz Dis 20(Suppl 2):S401–S412 doi: 10.1016/j.neuron.2008.10.047

Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002a) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539 doi: 10.1016/S0896-6273(03)00434-3

Hintersteiner M, Enz A, Frey P, Jaton AL, Kinzy W, Kneuer R, Neumann U, Rudin M, Staufenbiel M, Stoeckli M, Wiederhold KH, Gremlich HU (2005) In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe. Nat Biotechnol 23:577–583 doi: 10.1073/pnas.0808953105

Scattoni ML, Gasparini L, Alleva E, Goedert M, Calamandrei G, Spillantini MG (2010) Early behavioural markers of disease in P301S tau transgenic mice. Behav Brain Res 208:250–257 doi: 10.1146/annurev.neuro.21.1.479

Price DL, Sisodia SS, Borchelt DR (1998a) Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282:1079–1083 doi: 10.1126/science.282.5391.1079

Gau JT, Steinhilb ML, Kao TC, D’Amato CJ, Gaut JR, Frey KA, Turner RS (2002) Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice. Am J Pathol 160:731–738 doi: 10.1167/iovs.06-1029

 

DC FieldValueLanguage
dc.contributor.authorChiu, Ken_HK
dc.contributor.authorChan, TFen_HK
dc.contributor.authorWu, Aen_HK
dc.contributor.authorLeung, IYPen_HK
dc.contributor.authorSo, KFen_HK
dc.contributor.authorChang, RCCen_HK
dc.date.accessioned2011-07-27T01:25:51Z-
dc.date.available2011-07-27T01:25:51Z-
dc.date.issued2012en_HK
dc.identifier.citationAge, 2012, v. 34 n. 3, p. 633-649en_HK
dc.identifier.issn0161-9152en_HK
dc.identifier.urihttp://hdl.handle.net/10722/135016-
dc.description.abstractAlzheimer's disease (AD) is an age-related progressive neurodegenerative disease commonly found among elderly. In addition to cognitive and behavioral deficits, vision abnormalities are prevalent in AD patients. Recent studies investigating retinal changes in AD double-transgenic mice have shown altered processing of amyloid precursor protein and accumulation of β-amyloid peptides in neurons of retinal ganglion cell layer (RGCL) and inner nuclear layer (INL). Apoptotic cells were also detected in the RGCL. Thus, the pathophysiological changes of retinas in AD patients are possibly resembled by AD transgenic models. The retina is a simple model of the brain in the sense that some pathological changes and therapeutic strategies from the retina may be observed or applicable to the brain. Furthermore, it is also possible to advance our understanding of pathological mechanisms in other retinal degenerative diseases. Therefore, studying AD-related retinal degeneration is a promising way for the investigation on (1) AD pathologies and therapies that would eventually benefit the brain and (2) cellular mechanisms in other retinal degenerations such as glaucoma and age-related macular degeneration. This review will highlight the efforts on retinal degenerative research using AD transgenic mouse models. © 2011 The Author(s).en_HK
dc.languageengen_US
dc.publisherSpringer Netherlands. The Journal's web site is located at http://www.springerlink.com/content/0161-9152/en_HK
dc.relation.ispartofAgeen_HK
dc.rightsThe Author(s)en_US
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.en_US
dc.subjectAge-related macular degenerationen_HK
dc.subjectAlzheimer's diseaseen_HK
dc.subjectGlaucomaen_HK
dc.subjectInner nuclear layeren_HK
dc.subjectNeurodegenerationen_HK
dc.subjectRetinaen_HK
dc.subjectRetinal ganglion cellsen_HK
dc.titleNeurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?en_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4551/resserv?sid=springerlink&genre=article&atitle=Neurodegeneration of the retina in mouse models of Alzheimer’s disease: what can we learn from the retina?&title=AGE&issn=01619152&date=2011-05-11& spage=1&authors=Kin Chiu, Tin-Fung Chan, Andrew Wu, <i>et al.</i>en_US
dc.identifier.emailSo, KF:hrmaskf@hkucc.hku.hken_HK
dc.identifier.emailChang, RCC:rccchang@hkucc.hku.hken_HK
dc.identifier.authoritySo, KF=rp00329en_HK
dc.identifier.authorityChang, RCC=rp00470en_HK
dc.description.naturepublished_or_final_versionen_US
dc.identifier.doi10.1007/s11357-011-9260-2en_HK
dc.identifier.pmid21559868-
dc.identifier.pmcidPMC3337933-
dc.identifier.scopuseid_2-s2.0-84863717137en_HK
dc.identifier.hkuros186973en_US
dc.identifier.hkuros199701-
dc.relation.referencesAllen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22:9340–9351en_US
dc.relation.referencesAnderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411–431en_US
dc.relation.referencesdoi: 10.1016/S0002-9394(02)01624-0en_US
dc.relation.referencesAnderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV (2004) Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res 78:243–256en_US
dc.relation.referencesdoi: 10.1016/j.exer.2003.10.011en_US
dc.relation.referencesArendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF (2004) Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer’s disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res 1012:29–41en_US
dc.relation.referencesdoi: 10.1016/j.brainres.2004.02.081en_US
dc.relation.referencesBakalash S, Kipnis J, Yoles E, Schwartz M (2002) Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent. Invest Ophthalmol Vis Sci 43:2648–2653en_US
dc.relation.referencesBaum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Goggins WB, Zee BC, Cheng KF, Fong CY, Wong A, Mok H, Chow MS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CY, Chan MH, Szeto S, Chan IH, Mok V (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28:110–113en_US
dc.relation.referencesdoi: 10.1097/jcp.0b013e318160862cen_US
dc.relation.referencesBayer TA, Wirths O (2008) Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment. Genes Brain Behav 7(Suppl 1):6–11en_US
dc.relation.referencesdoi: 10.1007/s12177-009-9035-5en_US
dc.relation.referencesdoi: 10.1146/annurev.genet.32.1.461en_US
dc.relation.referencesRizzo M, Anderson SW, Dawson J, Nawrot M (2000) Vision and cognition in Alzheimer’s disease. Neuropsychologia 38:1157–1169en_US
dc.relation.referencesYu MS, Lai CS, Ho YS, Zee SY, So KF, Yuen WH, Chang RCC (2007) Characterization of the effects of anti-aging medicine Fructus lycii on beta-amyloid peptide neurotoxicity. Int J Mol Med 20:261–268en_US
dc.relation.referencesdoi: 10.1016/S0028-3932(00)00023-3en_US
dc.relation.referencesShimazawa M, Ito Y, Inokuchi Y, Hara H (2007) Involvement of Double-Stranded RNA-Dependent Protein Kinase in ER Stress-Induced Retinal Neuron Damage. Invest Ophthalmol Vis Sci 48:3729–3736en_US
dc.relation.referencesdoi: 10.1111/j.1471-4159.2007.04613.xen_US
dc.relation.referencesCarelli V, Ross-Cisneros FN, Sadun AA (2004) Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 23:53–89en_US
dc.relation.referencesKawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer’s disease. J Neurosci 21:372–381en_US
dc.relation.referencesdoi: 10.1016/j.bmcl.2010.09.029en_US
dc.relation.referencesdoi: 10.1007/s00281-008-0112-9en_US
dc.relation.referencesWalsh DT, Montero RM, Bresciani LG, Jen AY, Leclercq PD, Saunders D, EL-Amir AN, Gbadamoshi L, Gentleman SM, Jen LS (2002b) Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol Dis 10:20–27en_US
dc.relation.referencesRodrigues EB (2007) Inflammation in dry age-related macular degeneration. Ophthalmologica 221:143–152en_US
dc.relation.referencesdoi: 10.1111/j.1600-0420.1996.tb00090.xen_US
dc.relation.referencesSeo AY, Joseph A-M, Dutta D, Hwang JCY, Aris JP, Leeuwenburgh C (2010) New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci 123:2533–2542en_US
dc.relation.referencesChiu K, Zhou Y, Yeung SC, Lok CK, Chan OO, Chang RCC, So KF, Chiu JF (2010) Up-regulation of crystallins is involved in the neuroprotective effect of wolfberry on survival of retinal ganglion cells in rat ocular hypertension model. J Cell Biochem 110:311–320en_US
dc.relation.referencesdoi: 10.1242/jcs.070490en_US
dc.relation.referencesSpires TL, Hyman BT (2005) Transgenic models of Alzheimer’s disease: learning from animals. NeuroRx 2:423–437en_US
dc.relation.referencesdoi: 10.1602/neurorx.2.3.423en_US
dc.relation.referencesdoi: 10.1007/s10571-009-9419-xen_US
dc.relation.referencesStamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051–1063en_US
dc.relation.referencesdoi: 10.2174/156720510790274491en_US
dc.relation.referencesdoi: 10.1016/j.visres.2007.07.025en_US
dc.relation.referencesCaroni P (1997) Overexpression of growth-associated proteins in the neurons of adult transgenic mice. J Neurosci Methods 71:3–9en_US
dc.relation.referencesdoi: 10.1083/jcb.200108057en_US
dc.relation.referencesdoi: 10.1016/j.jalz.2007.04.381en_US
dc.relation.referencesdoi: 10.1016/j.tins.2010.05.004en_US
dc.relation.referencesdoi: 10.1016/j.jns.2006.02.009en_US
dc.relation.referencesdoi: 10.1167/iovs.06-0573en_US
dc.relation.referencesdoi: 10.1006/nbdi.2002.0485en_US
dc.relation.referencesdoi: 10.1016/j.neurobiolaging.2009.03.002en_US
dc.relation.referencesWan J, Fu AK, Ip FC, Ng HK, Hugon J, Page G, Wang JH, Lai KO, Wu Z, Ip NY (2010) Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer’s disease. J Neurosci 30:6873–6881en_US
dc.relation.referencesHardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356en_US
dc.relation.referencesdoi: 10.1523/JNEUROSCI.0519-10.2010en_US
dc.relation.referencesWang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Viola KL, Klein WL, Stine WB, Krafft GA, Trommer BL (2002) Soluble oligomers of beta amyloid (1–42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924:133–140en_US
dc.relation.referencesKlunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Långström B (2004) Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol 55:306–319en_US
dc.relation.referencesdoi: 10.1016/S0006-8993(01)03058-Xen_US
dc.relation.referencesJimenez S, Baglietto-Vargas D, Caballero C, Moreno-Gonzalez I, Torres M, Sanchez-Varo R, Ruano D, Vizuete M, Gutierrez A, Vitorica J (2008) Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer’s disease: age-dependent switch in the microglial phenotype from alternative to classic. J Neurosci 28:11650–11661en_US
dc.relation.referencesdoi: 10.1016/S0002-9440(10)64893-6en_US
dc.relation.referencesdoi: 10.1016/S0165-0270(96)00121-5en_US
dc.relation.referencesWang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. J Neurosci 29:9090–9103en_US
dc.relation.referencesTerwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P, Van Leuven F (2005) Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J Biol Chem 280:3963–3973en_US
dc.relation.referencesdoi: 10.1016/j.preteyeres.2003.10.003en_US
dc.relation.referencesdoi: 10.2741/1172en_US
dc.relation.referencesdoi: 10.1074/jbc.M404751200en_US
dc.relation.referencesMalamas MS, Robichaud A, Erdei J, Quagliato D, Solvibile W, Zhou P, Morris K, Turner J, Wagner E, Fan K, Olland A, Jacobsen S, Reinhart P, Riddell D, Pangalos M (2010) Design and synthesis of aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors with enhanced brain permeability. Bioorg Med Chem Lett 20:6597–6605en_US
dc.relation.referencesdoi: 10.1001/archopht.122.4.598en_US
dc.relation.referencesHo YS, Yu MS, Yik SY, So KF, Yuen WH, Chang RCC (2009) Polysaccharides from wolfberry antagonizes glutamate excitotoxicity in rat cortical neurons. Cell Mol Neurobiol 29:1233–1244en_US
dc.relation.referencesChang RCC, Suen KC, Ma CH, Elyaman W, Ng HK, Hugon J (2002a) Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2 alpha in neuronal degeneration. J Neurochem 83:1215–1225en_US
dc.relation.referencesdoi: 10.1523/JNEUROSCI.3024-08.2008en_US
dc.relation.referencesChang RCC, Wong AKY, Ng HK, Hugon J (2002b) Phosphorylation of eukaryotic initiation factor-2 alpha (eIF2 alpha) is associated with neuronal degeneration in Alzheimer’s disease. Neuroreport 13:2429–2432en_US
dc.relation.referencesCordeiro MF, Guo L, Coxon KM, Duggan J, Nizari S, Normando EM, Sensi SL, Sillito AM, Fitzke FW, Salt TE, Moss SE (2010) Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell Death Dis 1:e3en_US
dc.relation.referencesMcKinnon SJ (2003) Glaucoma: ocular Alzheimer’s disease? Front Biosci 8:s1140–s1156en_US
dc.relation.referencesGarcia MF, Gordon MN, Hutton M, Lewis J, McGowan E, Dickey CA, Morgan D, Arendash GW (2004) The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer’s transgenic mice. Neuroreport 15:73–77en_US
dc.relation.referencesdoi: 10.1126/science.1072994en_US
dc.relation.referencesLiu X, Hajnoczky G (2009) Ca2+−dependent regulation of mitochondrial dynamics by the Miro–Milton complex. Int J Biochem Cell Biol 41:1972–1976en_US
dc.relation.referencesHo YS, So KF, Chang RCC (2010b) Anti-aging herbal medicine—how and why can they be used in aging-associated neurodegenerative diseases? Ageing Res Rev 9:354–362en_US
dc.relation.referencesDutescu RM, Li QX, Crowston J, Masters CL, Baird PN, Culvenor JG (2009) Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease. Graefes Arch Clin Exp Ophthalmol 247:1213–1221en_US
dc.relation.referencesGruart A, Lopez-Ramos JC, Munoz MD, Delgado-Garcia JM (2008) Aged wild-type and APP, PS1, and APP + PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load. Neurobiol Dis 30:439–450en_US
dc.relation.referencesYoshida T, Ohno-Matsui K, Ichinose S, Sato T, Iwata N, Saido TC, Hisatomi T, Mochizuki M, Morita I (2005) The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest 115:2793–2800en_US
dc.relation.referencesSuen KC, Yu MS, So KF, Chang RCC, Hugon J (2003) Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in {beta}-amyloid peptide neurotoxicity. J Biol Chem 278:49819–49827en_US
dc.relation.referencesJohnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH (2002) The Alzheimer’s A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA 99:11830–11835en_US
dc.relation.referencesWesterman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH (2002) The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer’s disease. J Neurosci 22:1858–1867en_US
dc.relation.referencesCasas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, Drobecq H, Clark A, Bonici B, Delacourte A, Benavides J, Schmitz C, Tremp G, Bayer TA, Benoit P, Pradier L (2004) Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 165:1289–1300en_US
dc.relation.referencesdoi: 10.1016/S0002-9440(10)63388-3en_US
dc.relation.referencesNimmrich V, Grimm C, Draguhn A, Barghorn S, Lehmann A, Schoemaker H, Hillen H, Gross G, Ebert U, Bruehl C (2008) Amyloid beta oligomers (A beta(1–42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci 28:788–797en_US
dc.relation.referencesdoi: 10.1016/S0166-4328(99)00037-6en_US
dc.relation.referencesChan HC, Chang RCC, Koon-Ching Ip A, Chiu K, Yuen WH, Zee SY, So KF (2007) Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Exp Neurol 203:269–273en_US
dc.relation.referencesdoi: 10.1016/j.biocel.2009.05.013en_US
dc.relation.referencesdoi: 10.1016/j.expneurol.2006.05.031en_US
dc.relation.referencesChiu K, Lam TT, Ying Li WW, Caprioli J, Kwong JM (2005) Calpain and N-methyl-d-aspartate (NMDA)-induced excitotoxicity in rat retinas. Brain Res 1046:207–215en_US
dc.relation.referencesHo YS, Yu MS, Yang XF, So KF, Yuen WH, Chang RCC (2010a) Neuroprotective effects of polysaccharides from wolfberry, the fruits of Lycium barbarum, against homocysteine-induced toxicity in rat cortical neurons. J Alzheimers Dis 19:813–827en_US
dc.relation.referencesdoi: 10.1016/j.brainres.2005.04.016en_US
dc.relation.referencesdoi: 10.1073/pnas.192203399en_US
dc.relation.referencesMuyllaert D, Kremer A, Jaworski T, Borghgraef P, Devijver H, Croes S, Dewachter I, Van Leuven F (2008) Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology? Genes Brain Behav 7(Suppl 1):57–66en_US
dc.relation.referencesKong GY, Van Bergen NJ, Trounce IA, Crowston JG (2009) Mitochondrial dysfunction and glaucoma. J Glaucoma 18:93–100en_US
dc.relation.referencesRon B, Elizabeth J, Kathryn Z-G, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alz Dement 3:186–191en_US
dc.relation.referencesGold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, Hageman GS, Dean M, Allikmets R, AMD Genetics Clinical Study Group (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38:458–462en_US
dc.relation.referencesChiu K, Chang RCC, So KF (2007) Intravitreous injection for establishing ocular diseases model. J Vis Exp 8:313en_US
dc.relation.referencesBerisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL (2007) Retinal abnormalities in early Alzheimer’s disease. Invest Ophthalmol Vis Sci 48:2285–2289en_US
dc.relation.referencesdoi: 10.1007/s00417-009-1060-3en_US
dc.relation.referencesLiu B, Rasool S, Yang Z, Glabe CG, Schreiber SS, Ge J, Tan Z (2009) Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer’s transgenic mice. Am J Pathol 175:2099–2110en_US
dc.relation.referencesDuyckaerts C, Potier MC, Delatour B (2008) Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol 115:5–38en_US
dc.relation.referencesdoi: 10.1007/s00401-007-0312-8en_US
dc.relation.referencesEriksen JL, Janus CG (2007) Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet 37:79–100en_US
dc.relation.referencesdoi: 10.1167/iovs.08-2384en_US
dc.relation.referencesdoi: 10.1016/j.preteyeres.2004.05.001en_US
dc.relation.referencesKoronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL (2011) Identification of amyloid plaques in retinas from Alzheimer’s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54(Suppl 1):S204–S217en_US
dc.relation.referencesdoi: 10.1007/s10519-006-9118-zen_US
dc.relation.referencesNakada T, Matsuzawa H, Igarashi H, Fujii Y, Kwee IL (2008) In vivo visualization of senile-plaque-like pathology in Alzheimer’s disease patients by MR microscopy on a 7T system. J Neuroimaging 18:125–129en_US
dc.relation.referencesFrank S, Clavaguera F, Tolnay M (2008) Tauopathy models and human neuropathology: similarities and differences. Acta Neuropathol 115:39–53en_US
dc.relation.referencesdoi: 10.1007/s00401-007-0291-9en_US
dc.relation.referencesdoi: 10.1002/ana.20009en_US
dc.relation.referencesGarcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP (2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24:516–524en_US
dc.relation.referencesdoi: 10.2353/ajpath.2009.090159en_US
dc.relation.referencesPatel M, Chan CC (2008) Immunopathological aspects of age-related macular degeneration. Semin Immunopathol 30:97–110en_US
dc.relation.referencesMcKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, Ransom NL, Tahzib NG, Reitsamer HA, Levkovitch-Verbin H, Quigley HA, Zack DJ (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43:1077–1087en_US
dc.relation.referencesdoi: 10.4061/2010/417314en_US
dc.relation.referencesdoi: 10.1016/j.mehy.2008.01.030en_US
dc.relation.referencesdoi: 10.1016/j.arr.2009.10.001en_US
dc.relation.referencesdoi: 10.1016/j.nbd.2006.08.017en_US
dc.relation.referencesdoi: 10.1159/000099293en_US
dc.relation.referencesdoi: 10.1038/ng1750en_US
dc.relation.referencesdoi: 10.1111/j.1552-6569.2007.00179.xen_US
dc.relation.referencesGrundke-Iqbal I, Iqbal K, George L, Tung YC, Kim KS, Wisniewski HM (1989) Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc Natl Acad Sci USA 86:2853–2857en_US
dc.relation.referencesdoi: 10.1073/pnas.86.8.2853en_US
dc.relation.referencesGuo L, Salt TE et al (2007) Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA 104:13444–13449en_US
dc.relation.referencesdoi: 10.1002/glia.440030605en_US
dc.relation.referencesdoi: 10.1073/pnas.0703707104en_US
dc.relation.referencesdoi: 10.1159/000047976en_US
dc.relation.referencesMey J, Thanos S (1993) Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 602:304–317en_US
dc.relation.referencesGuo L, Duggan J, Cordeiro MF (2010) Alzheimer’s disease and retinal neurodegeneration. Curr Alzheimer Res 7:3–14en_US
dc.relation.referencesGasparini L, Anthony Crowther R, Martin KR, Berg N, Coleman M, Goedert M, Spillantini MG (2009) Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Neurobiol Aging 32:419–433en_US
dc.relation.referencesdoi: 10.1097/IJG.0b013e318181284fen_US
dc.relation.referencesHedges TR 3rd, Perez Galves R, Speigelman D, Barbas NR, Peli E, Yardley CJ (1996) Retinal nerve fiber layer abnormalities in Alzheimer’s disease. Acta Ophthalmol Scand 74:271–275en_US
dc.relation.referencesTanghe A, Termont A, Merchiers P, Schilling S, Demuth HU, Scrocchi L, Van Leuven F, Griffioen G, Van Dooren T (2010) Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer’s Disease of the APP[V717I] London Transgenic Mouse Model. Int J Alzheimers Dis doi:10.4061/2010/417314en_US
dc.relation.referencesHsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99–102en_US
dc.relation.referencesPerez SE, Lumayag S, Kovacs B, Mufson EJ, Xu S (2009) Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer’s disease. Invest Ophthalmol Vis Sci 50:793–800en_US
dc.relation.referencesdoi: 10.1126/science.274.5284.99en_US
dc.relation.referencesHung CH, Ho YS, Chang RCC (2010) Modulation of mitochondrial calcium as a pharmacological target for Alzheimer’s disease. Ageing Res Rev 9:447–456en_US
dc.relation.referencesdoi: 10.1016/j.arr.2010.05.003en_US
dc.relation.referencesValenti DA (2010) Alzheimer’s disease: visual system review. Optometry 81:12–21en_US
dc.relation.referencesJi JZ, Elyaman W, Yip HK, Lee VW, Yick LW, Hugon J, So KF (2004) CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur J Neurosci 19:265–272en_US
dc.relation.referencesSuo Z, Cox AA, Bartelli N, Rasul I, Festoff BW, Premont RT, Arendash GW (2007) GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment. Neurobiol Aging 28:1873–1888en_US
dc.relation.referencesPezzini A, Del Zotto E, Volonghi I, Giossi A, Costa P, Padovani A (2009) Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage. Curr Med Chem 16:2498–2513en_US
dc.relation.referencesdoi: 10.1016/0006-8993(93)90695-Jen_US
dc.relation.referencesdoi: 10.1111/j.0953-816X.2003.03107.xen_US
dc.relation.referencesdoi: 10.1038/nbt1085en_US
dc.relation.referencesMendez MF, Mendez MA, Martin R, Smyth KA, Whitehouse PJ (1990) Complex visual disturbances in Alzheimer’s disease. Neurology 40:439–443en_US
dc.relation.referencesJu WK, Liu Q, Kim KY, Crowston JG, Lindsey JD, Agarwal N, Ellisman MH, Perkins GA, Weinreb RN (2007) Elevated hydrostatic pressure triggers mitochondrial fission and decreases cellular ATP in differentiated RGC-5 cells. Invest Ophthalmol Vis Sci 48:2145–2151en_US
dc.relation.referencesYin H, Chen L, Chen X, Liu X (2008) Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma. Med Hypotheses 71:77–80en_US
dc.relation.referencesdoi: 10.1016/j.neuroimage.2010.06.020en_US
dc.relation.referencesRoque RS, Caldwell RB (1990) Müller cell changes precede vascularization of the pigment epithelium in the dystrophic rat retina. Glia 3:464–475en_US
dc.relation.referencesLaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci 8:499–509en_US
dc.relation.referencesdoi: 10.1016/j.neurobiolaging.2006.08.013en_US
dc.relation.referencesdoi: 10.1038/nrn2168en_US
dc.relation.referencesLe Cudennec C, Faure A, Ly M, Delatour B (2008) One-year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice. Genes Brain Behav 7(Suppl 1):83–91en_US
dc.relation.referencesYu MS, Ho YS, So KF, Yuen WH, Chang RCC (2006) Cytoprotective effects of Lycium barbarum against reducing stress on endoplasmic reticulum. Int J Mol Med 17:1157–1161en_US
dc.relation.referencesLi M, Chen L, Lee DH, Yu LC, Zhang Y (2007) The role of intracellular amyloid beta in Alzheimer’s disease. Prog Neurobiol 83:131–139en_US
dc.relation.referencesdoi: 10.1523/JNEUROSCI.1357-09.2009en_US
dc.relation.referencesSaotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, Rizzuto R, Hajnoczky G (2008) Bidirectional Ca2+−dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci USA 105:20728–20733en_US
dc.relation.referencesdoi: 10.1523/JNEUROSCI.4771-07.2008en_US
dc.relation.referencesdoi: 10.1016/j.pneurobio.2007.08.002en_US
dc.relation.referencesKing DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ (1999) Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer’s disease. Behav Brain Res 103:145–162en_US
dc.relation.referencesLuibl V, Isas JM, Kayed R, Glabe CG, Langen R, Chen J (2006) Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest 116:378–385en_US
dc.relation.referencesdoi: 10.1016/0197-4580(96)00010-3en_US
dc.relation.referencesdoi: 10.1172/JCI25843en_US
dc.relation.referencesBayer AU, Ferrari F, Erb C (2002) High occurrence rate of glaucoma among patients with Alzheimer’s disease. Eur Neurol 47:165–168en_US
dc.relation.referencesMoechars D, Dewachter I, Lorent K, Reversé D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274:6483–6492en_US
dc.relation.referencesdoi: 10.1074/jbc.M409876200en_US
dc.relation.referencesdoi: 10.1074/jbc.274.10.6483en_US
dc.relation.referencesWostyn P, Audenaert K, De Deyn PP (2008) Alzheimer’s disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure. Clin Neurol Neurosurg 110:101–109en_US
dc.relation.referencesMorgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease. Nature 408:982–985en_US
dc.relation.referencesdoi: 10.1038/35050116en_US
dc.relation.referencesBlanks JC, Torigoe Y, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer’s disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 17:377–384en_US
dc.relation.referencesMorin PJ, Abraham CR, Amaratunga A, Johnson RJ, Huber G, Sandell JH, Fine RE (1993) Amyloid precursor protein is synthesized by retinal ganglion cells, rapidly transported to the optic nerve plasma membrane and nerve terminals, and metabolized. J Neurochem 61:464–473en_US
dc.relation.referencesTamura H, Kawakami H, Kanamoto T, Kato T, Yokoyama T, Sasaki K, Izumi Y, Matsumoto M, Mishima HK (2006) High frequency of open-angle glaucoma in Japanese patients with Alzheimer’s disease. J Neurol Sci 246:79–83en_US
dc.relation.referencesPierce EA, Avery RL, Foley ED, Aiello LP, Smith LE (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905–909en_US
dc.relation.referencesdoi: 10.1038/416535aen_US
dc.relation.referencesdoi: 10.2174/092986709788682047en_US
dc.relation.referencesdoi: 10.1111/j.1471-4159.1993.tb02147.xen_US
dc.relation.referencesMargrain TH, Boulton M, Marshall J, Sliney DH (2004) Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res 23:523–531en_US
dc.relation.referencesNing A, Cui J, To E, Ashe KH, Matsubara J (2008) Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci 49:5136–5143en_US
dc.relation.referencesdoi: 10.1016/j.clineuro.2007.10.011en_US
dc.relation.referencesdoi: 10.1167/iovs.08-1849en_US
dc.relation.referencesNozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, Chen Y, Zhang K, Ambati BK, Baffi JZ, Ambati J (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 103:2328–2333en_US
dc.relation.referencesdoi: 10.1073/pnas.0408835103en_US
dc.relation.referencesDing JD, Lin J, Mace BE, Herrmann R, Sullivan P, Bowes Rickman C (2008) Targeting age-related macular degeneration with Alzheimer’s disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Vision Res 48:339–345en_US
dc.relation.referencesdoi: 10.1172/JCI24635en_US
dc.relation.referencesO’Connor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, Cole SL, Eimer WA, Hitt B, Bembinster LA, Lammich S, Lichtenthaler SF, Hébert SS, De Strooper B, Haass C, Bennett DA, Vassar R (2008) Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60:988–1009en_US
dc.relation.referencesSantos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI, Zhu X (2010) A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer’s disease. J Alz Dis 20(Suppl 2):S401–S412en_US
dc.relation.referencesdoi: 10.1016/j.neuron.2008.10.047en_US
dc.relation.referencesOddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409–421en_US
dc.relation.referencesWalsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002a) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539en_US
dc.relation.referencesdoi: 10.1016/S0896-6273(03)00434-3en_US
dc.relation.referencesYang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892–5901en_US
dc.relation.referencesChiu K, Chan HC, Yeung SC, Yuen WH, Zee SY, Chang RCC, So KF (2009) Modulation of microglia by wolfberry on the survival of retinal ganglion cells in a rat ocular hypertension model. J Ocul Biol Dis Infor 2:127–136en_US
dc.relation.referencesZahs KR, Ashe KH (2010) ‘Too much good news’—are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer’s disease? Trends Neurosci 33:381–389en_US
dc.relation.referencesHintersteiner M, Enz A, Frey P, Jaton AL, Kinzy W, Kneuer R, Neumann U, Rudin M, Staufenbiel M, Stoeckli M, Wiederhold KH, Gremlich HU (2005) In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe. Nat Biotechnol 23:577–583en_US
dc.relation.referencesdoi: 10.1073/pnas.0808953105en_US
dc.relation.referencesOhyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K, Yamada T, Kikuchi H, Taniwaki T, Murai H, Ikezoe K, Furuya H, Kawarabayashi T, Shoji M, Checler F, Iwaki T, Makifuchi T, Takeda K, Kira J, Tabira T (2005) Intracellular Aß42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer’s disease. FASEB J 19:255–257en_US
dc.relation.referencesGarcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102:1095–1104en_US
dc.relation.referencesPrice DL, Sisodia SS (1998) Mutant genes in familial Alzheimer’s disease and transgenic models. Annu Rev Neurosci 21:479–505en_US
dc.relation.referencesScattoni ML, Gasparini L, Alleva E, Goedert M, Calamandrei G, Spillantini MG (2010) Early behavioural markers of disease in P301S tau transgenic mice. Behav Brain Res 208:250–257en_US
dc.relation.referencesdoi: 10.1146/annurev.neuro.21.1.479en_US
dc.relation.referencesPrice DL, Sisodia SS, Borchelt DR (1998a) Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282:1079–1083en_US
dc.relation.referencesdoi: 10.1126/science.282.5391.1079en_US
dc.relation.referencesGau JT, Steinhilb ML, Kao TC, D’Amato CJ, Gaut JR, Frey KA, Turner RS (2002) Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice. Am J Pathol 160:731–738en_US
dc.relation.referencesdoi: 10.1167/iovs.06-1029en_US
dc.relation.referencesZarbin MA (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122:598–614en_US
dc.relation.referencesPrice DL, Tanzi RE, Borchelt DR, Sisodia SS (1998b) Alzheimer’s disease: genetic studies and transgenic models. Annu Rev Genet 32:461–493en_US
dc.identifier.volume34-
dc.identifier.issue3-
dc.identifier.spage1en_HK
dc.identifier.spage633-
dc.identifier.epage17en_HK
dc.identifier.epage649-
dc.identifier.eissn1574-4647en_US
dc.identifier.isiWOS:000303507400010-
dc.publisher.placeNetherlandsen_HK
dc.description.otherSpringer Open Choice, 21 Feb 2012en_US
dc.identifier.scopusauthoridChiu, K=15076970500en_HK
dc.identifier.scopusauthoridChan, TF=37118537600en_HK
dc.identifier.scopusauthoridWu, A=37119578800en_HK
dc.identifier.scopusauthoridLeung, IYP=37119139600en_HK
dc.identifier.scopusauthoridSo, KF=34668391300en_HK
dc.identifier.scopusauthoridChang, RCC=7403713410en_HK
dc.identifier.citeulike9313839-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats